Clinical Trials Browser

Interventional × Prostatic Neoplasms × clevudine × Clear all

NCT02809690 2023-09-07

18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Phase 1 Terminated

Prostatic Neoplasms

NCT01812668 2021-08-05

Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Phase NA Completed

20 enrolled 12 charts

Prostatic Neoplasms